Takeda Pharmaceutical Co Ltd at Morgan Stanley Global Healthcare Conference Transcript
We'll get start with our next session. I'm Shinichiro Muraoka of Morgan Stanley Japan Pharmaceutical team. And today, in this session with Takeda Pharmaceutical -- sorry, before starting that. So important disclosures, please see the Morgan Stanley Research Disclosure website at www.morganstanley.com/disclosures. If you have any questions, please reach out to your Morgan Stanley sales representative. So let's start. So today, we are with Andy Plump of -- President of R&D of Takeda; and Costa Saroukos, CFO. Thank you, Andy and Costa for joining us. Thank you.
Questions & Answers
So let's get start my question first to Costa about earnings for this year, next year and beyond. First, in this year, your last quarter earnings were quite good, not just with currency support, but quite good earnings. Could you -- I believe
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
